Clot accumulation characteristics of plasminogen-bearing liposomes in a flow-system

Thrombosis and Haemostasis

Volumn 79, Issue 1, 1998, Pages 144-149

  Heeremans, J L M ^a,c   Prevost, R ^a,c   Feitsma, H ^b   Kluft, C ^c   Crommelin, D J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; FIBRIN; LIPOSOME; PLASMINOGEN;

ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; DRUG ACCUMULATION; FIBRIN CLOT; ISOTOPE LABELING; PRIORITY JOURNAL;

EID: 0031984478     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614234     Document Type: Article

References (18)

1. Crommelin DJA, Schreier H. Liposomes. In: Colloidal drug delivery systems, Kreuter J, ed. New York: Marcel Dekker Inc 1994; pp 73-90.
2. Crommelin DJA, Scherphof G, Storm G. Active targeting with particulate carrier systems in the blood compartment. Adv Drug Del Rev 1995; 17: 49-60.
3. Heeremans JLM, Kraaijenga JJ, Los P, Kluft C, Crommelin DJA. Development of a procedure for coupling the homing device Glu-plasminogen to liposomes. Biochim Biophys Acta 1992; 1117: 258-64.
4. Heeremans JLM, Crommelin DJA, Kluft C. Pharmaceutical composition for site-specific release of a clot-dissolving protein. Internat. Patent Appl. No. WO 94/07537, 1994.
5. Heeremans JLM, Prevost R, Bekkers MEA, Los P, Emeis JJ, Kluft C, Crommelin DJA. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb Haemost 1995; 73: 488-94.
6. Heeremans JLM, Los P, Prevost R, Crommelin DJA, Kluft C. Fibrin binding of Glu-plasminogen coated liposomes in vitro. Thromb Haemost 1996; 75: 134-9.
7. Martin FJ, Papahadjopoulos D. Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. J Biol Chem 1982; 257: 286-8.
8. Ruyven-Vermeer IAM van, Nieuwenhuizen W. Purification of rat fibrinogen and its constituent chains. Biochem J 1978; 169: 653-8.
9. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238-52.
10. Heeremans JLM, Prevost R, Bischot L, Los P, Kluft C, Crommelin DJA. Interference of ε-amino-caproic acid with [N-succinimidyl S-acethylacetate derived] thiol introduction into Glu-plasminogen. Fibrinolysis 1994; 8, S2: 138-41.
11. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble choloroamide, 1,3,4,6,-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
12. Duncan RJS, Weston PD, Wrigglesworth R. A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal Biochem 1983; 132: 68-73.
13. Sakharov DV, Rijken DC. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 1995; 92: 1883-90.
14. Thorsen S. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis. Ann N Y Acad Sci 1992; 667: 52-63.
15. Bell GI. Physical chemical aspects of cell surface events in cellular regulation: Delisi C, Blumenthal R, eds., North-Holland: Elsevier NY 1979.
16. Ho RJY, Rouse BT, Huang L. Target-sensitive immunoliposomes: preparation and characterization. Biochemistry 1986; 25: 5500-6.
17. Ho RJY, Rouse BT, Huang L. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity. J Biol Chem 1987; 262: 13973-8.
18. Wasser MNJM, Nieuwenhuizen W, Pauwels EKJ. Scintigraphic detection of thrombi using a Tc-99m labelled antifibrin monoclonal antibody: experiments in vitro and in animals. Proc symposium Clinical use of monoclonal antibodies. Amsterdam 1988: 122.